Exercise to Boost Response to Checkpoint Blockade Immunotherapy

Clinical trial NCT06008977 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06008977
Sponsor: AdventHealth Translational Research Institute
Status: ACTIVE_NOT_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Cutaneous Melanoma Cutaneous Squamous Cell Carcinoma Merkel Cell Carcinoma

Start date: 2024-06-03
Primary completion: 2025-08-07
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.